Kinase Inhibitor [EPC]

Kinase Inhibitor [EPC] was reported 557577 times

Drugs of the Kinase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EGFR GENE MUTATION 285 0.7620
1 ACQUIRED GENE MUTATION 671 0.5118
2 NEOPLASM PROGRESSION 16263 0.4672
3 TRYPTASE INCREASED 309 0.4328
4 MYELOFIBROSIS 1013 0.3347
5 CARBOHYDRATE ANTIGEN 15-3 INCREASED 254 0.3338
6 METASTASES TO MENINGES 712 0.3128
7 MANTLE CELL LYMPHOMA 476 0.3125
8 HAEMATOCRIT ABNORMAL 375 0.3049
9 TUMOUR MARKER INCREASED 1377 0.2867
10 METASTASES TO PLEURA 282 0.2688
11 HEPATOCELLULAR CARCINOMA 2026 0.2662
12 LYMPHANGIOSIS CARCINOMATOSA 275 0.2639
13 NON-SMALL CELL LUNG CANCER 1212 0.2528
14 METASTATIC RENAL CELL CARCINOMA 459 0.2505
15 METASTASES TO ADRENALS 227 0.2459
16 PARONYCHIA 1067 0.2426
17 POLYOMAVIRUS VIRAEMIA 257 0.2420
18 WHITE BLOOD CELL COUNT ABNORMAL 1539 0.2409
19 METASTASES TO CENTRAL NERVOUS SYSTEM 3095 0.2397
20 CHRONIC LYMPHOCYTIC LEUKAEMIA 1111 0.2339
21 RED BLOOD CELL COUNT ABNORMAL 338 0.2299
22 ONYCHOCLASIS 1571 0.2280
23 MALIGNANT PLEURAL EFFUSION 381 0.2257
24 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 523 0.2230
25 CYTOGENETIC ANALYSIS ABNORMAL 230 0.2195
26 PLATELET COUNT ABNORMAL 1315 0.2173
27 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5040 0.2160
28 SPLENOMEGALY 2520 0.2149
29 TUMOUR PAIN 276 0.2094
30 MALIGNANT NEOPLASM PROGRESSION 20889 0.2038
31 MEDICAL PROCEDURE 332 0.1994
32 SECOND PRIMARY MALIGNANCY 1656 0.1989
33 BLOOD COUNT ABNORMAL 2931 0.1931
34 METASTASES TO BONE 3144 0.1914
35 CANCER PAIN 484 0.1891
36 HEPATIC NEOPLASM MALIGNANT 397 0.1874
37 CARCINOEMBRYONIC ANTIGEN INCREASED 362 0.1867
38 LYMPHOCYTOSIS 401 0.1862
39 METASTASES TO LUNG 2147 0.1856
40 STOMATITIS 11216 0.1847
41 FULL BLOOD COUNT ABNORMAL 1931 0.1824
42 CHRONIC GRAFT VERSUS HOST DISEASE 659 0.1823
43 GRAFT VERSUS HOST DISEASE IN SKIN 392 0.1778
44 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 377 0.1770
45 METASTASES TO SPINE 593 0.1763
46 BREAST CANCER METASTATIC 1878 0.1747
47 HAEMATOCRIT INCREASED 398 0.1745
48 NEUROENDOCRINE TUMOUR 241 0.1701
49 BK VIRUS INFECTION 570 0.1688
50 SPLEEN DISORDER 286 0.1687
51 METASTASES TO LIVER 2967 0.1686
52 SKIN TOXICITY 911 0.1610
53 PLATELET COUNT INCREASED 2067 0.1584
54 HYPERKERATOSIS 859 0.1556
55 WHITE BLOOD CELL COUNT DECREASED 16777 0.1546
56 RENAL CELL CARCINOMA 757 0.1546
57 GENE MUTATION 305 0.1540
58 FULL BLOOD COUNT DECREASED 3038 0.1506
59 RED BLOOD CELL COUNT DECREASED 4308 0.1505
60 TUMOUR HAEMORRHAGE 429 0.1502
61 CYTOPENIA 1814 0.1480
62 METASTASES TO PERITONEUM 373 0.1475
63 METASTASES TO LYMPH NODES 988 0.1462
64 PNEUMONITIS 3907 0.1433
65 HAEMOGLOBIN ABNORMAL 920 0.1429
66 NAIL DISORDER 1227 0.1401
67 INCREASED TENDENCY TO BRUISE 1265 0.1374
68 DERMATITIS ACNEIFORM 832 0.1366
69 ASPERGILLUS INFECTION 897 0.1365
70 DRUG RESISTANCE 3429 0.1334
71 DISEASE PROGRESSION 15628 0.1319
72 CYTOMEGALOVIRUS INFECTION REACTIVATION 580 0.1312
73 ORAL PAIN 2915 0.1301
74 GRAFT VERSUS HOST DISEASE 929 0.1291
75 METASTASIS 907 0.1269
76 HEPATIC LESION 549 0.1268
77 LYMPHOCYTE COUNT INCREASED 413 0.1264
78 LYMPHOEDEMA 867 0.1253
79 NEOPLASM RECURRENCE 425 0.1252
80 EARLY SATIETY 243 0.1247
81 WHITE BLOOD CELL DISORDER 331 0.1236
82 SQUAMOUS CELL CARCINOMA OF SKIN 745 0.1233
83 HEPATIC ENCEPHALOPATHY 1138 0.1218
84 ADENOVIRUS INFECTION 352 0.1213
85 HAEMORRHAGIC DIATHESIS 430 0.1207
86 RED BLOOD CELL COUNT INCREASED 322 0.1167
87 BLOOD BLISTER 363 0.1160
88 MEAN CELL VOLUME INCREASED 296 0.1152
89 PLEURAL EFFUSION 6762 0.1110
90 HOSPICE CARE 1093 0.1105
91 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 563 0.1105
92 GASTROINTESTINAL TOXICITY 531 0.1104
93 SQUAMOUS CELL CARCINOMA 1037 0.1100
94 PROTEINURIA 2082 0.1094
95 PLATELET COUNT DECREASED 11647 0.1092
96 HAEMATOTOXICITY 1037 0.1090
97 ACUTE MYELOID LEUKAEMIA RECURRENT 231 0.1075
98 HYPERPHOSPHATAEMIA 231 0.1073
99 INGROWING NAIL 251 0.1061
100 LUNG ADENOCARCINOMA 319 0.1059
101 HAEMOGLOBIN INCREASED 479 0.1049
102 BONE MARROW DISORDER 312 0.1032
103 ACUTE GRAFT VERSUS HOST DISEASE 472 0.1030
104 WHITE BLOOD CELL COUNT INCREASED 3944 0.1027
105 TUMOUR LYSIS SYNDROME 900 0.1022
106 NEUTROPHIL COUNT DECREASED 4137 0.1014
107 ASCITES 2966 0.1008
108 OESOPHAGEAL VARICES HAEMORRHAGE 219 0.1008
109 BONE LESION 356 0.0986
110 PETECHIAE 1028 0.0984
111 PERIORBITAL SWELLING 555 0.0981
112 MUCOSAL INFLAMMATION 2555 0.0975
113 APHTHOUS ULCER 756 0.0974
114 PRODUCT AVAILABILITY ISSUE 2198 0.0964
115 RED CELL DISTRIBUTION WIDTH INCREASED 401 0.0964
116 SKIN PAPILLOMA 386 0.0962
117 AMYLASE INCREASED 353 0.0956
118 THROMBOTIC MICROANGIOPATHY 924 0.0947
119 PLATELET DISORDER 239 0.0947
120 HAEMOTHORAX 273 0.0940
121 NEOPLASM 1078 0.0937
122 NAIL DISCOLOURATION 366 0.0930
123 TRANSPLANT REJECTION 742 0.0925
124 TASTE DISORDER 1877 0.0924
125 NEUTROPHIL COUNT ABNORMAL 259 0.0916
126 BREAST CANCER RECURRENT 285 0.0901
127 BONE MARROW FAILURE 1811 0.0890
128 LUNG OPACITY 234 0.0887
129 NEUTROPENIA 12061 0.0886
130 DECREASED ACTIVITY 948 0.0878
131 DECREASED IMMUNE RESPONSIVENESS 861 0.0877
132 INTERSTITIAL LUNG DISEASE 4248 0.0876
133 HAEMOGLOBIN DECREASED 8992 0.0875
134 AMMONIA INCREASED 446 0.0873
135 MOUTH ULCERATION 1838 0.0871
136 HEPATIC FUNCTION ABNORMAL 3214 0.0860
137 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 238 0.0860
138 HYPERTRIGLYCERIDAEMIA 504 0.0860
139 BLOOD TEST ABNORMAL 1197 0.0851
140 PERICARDIAL EFFUSION 1961 0.0847
141 BRONCHOPULMONARY ASPERGILLOSIS 653 0.0841
142 PULMONARY TOXICITY 589 0.0832
143 HYPERURICAEMIA 342 0.0831
144 THERAPY PARTIAL RESPONDER 1276 0.0817
145 PNEUMONIA FUNGAL 321 0.0813
146 HEPATIC NEOPLASM 265 0.0811
147 EPSTEIN-BARR VIRUS INFECTION 504 0.0806
148 RENAL FUNCTION TEST ABNORMAL 374 0.0805
149 DECREASED APPETITE 18615 0.0801
150 PNEUMATOSIS INTESTINALIS 228 0.0799
151 THYROIDITIS 240 0.0798
152 TONGUE ULCERATION 270 0.0798
153 BLOOD IRON DECREASED 914 0.0769
154 BLOOD URIC ACID INCREASED 442 0.0765
155 EPISTAXIS 5723 0.0764
156 PORTAL VEIN THROMBOSIS 246 0.0761
157 CYTOMEGALOVIRUS VIRAEMIA 337 0.0757
158 AUTOIMMUNE HAEMOLYTIC ANAEMIA 259 0.0755
159 PNEUMOCYSTIS JIROVECII PNEUMONIA 758 0.0754
160 RECURRENT CANCER 307 0.0752
161 HAEMORRHAGE SUBCUTANEOUS 265 0.0746
162 ONYCHOMADESIS 313 0.0745
163 MYELOSUPPRESSION 2668 0.0740
164 CACHEXIA 380 0.0738
165 BLOOD LACTATE DEHYDROGENASE INCREASED 1168 0.0736
166 HAEMATOCRIT DECREASED 1461 0.0736
167 MELANOCYTIC NAEVUS 323 0.0736
168 BLOOD BILIRUBIN INCREASED 1972 0.0729
169 PROTEIN TOTAL DECREASED 274 0.0727
170 GASTROINTESTINAL PERFORATION 301 0.0723
171 CARDIAC DYSFUNCTION 269 0.0722
172 HYPOALBUMINAEMIA 562 0.0722
173 HEPATOTOXICITY 1607 0.0721
174 METASTATIC NEOPLASM 311 0.0720
175 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 688 0.0720
176 DIARRHOEA 46391 0.0718
177 HYPOGAMMAGLOBULINAEMIA 472 0.0718
178 URINARY TRACT DISORDER 323 0.0717
179 LYMPHADENOPATHY 2536 0.0716
180 SUNBURN 532 0.0713
181 HYPOTHYROIDISM 2274 0.0711
182 ADRENAL INSUFFICIENCY 859 0.0707
183 THROMBOCYTOPENIA 7895 0.0705
184 BRAIN FOG 1104 0.0704
185 LABORATORY TEST ABNORMAL 2072 0.0701
186 DEATH 60120 0.0697
187 ANAEMIA 13223 0.0693
188 BLOOD CREATININE ABNORMAL 237 0.0685
189 CONTUSION 6559 0.0681
190 PULMONARY MASS 1011 0.0678
191 BONE CANCER 295 0.0678
192 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 224 0.0678
193 BONE PAIN 3971 0.0677
194 PNEUMOTHORAX 1075 0.0677
195 CHOLANGITIS 420 0.0677
196 CYTOMEGALOVIRUS INFECTION 1119 0.0673
197 NEPHROTIC SYNDROME 458 0.0667
198 WOUND HAEMORRHAGE 247 0.0667
199 MASS 933 0.0667
200 FEEDING DISORDER 1349 0.0664
201 CHRONIC MYELOID LEUKAEMIA 307 0.0664
202 DYSPHONIA 3886 0.0664
203 BLOOD ALBUMIN DECREASED 527 0.0664
204 APPETITE DISORDER 440 0.0663
205 THROMBOCYTOSIS 243 0.0662
206 HEPATIC PAIN 281 0.0657
207 HYPERTRANSAMINASAEMIA 457 0.0656
208 BLOOD DISORDER 526 0.0656
209 ATRIAL FIBRILLATION 6392 0.0656
210 BLOOD SODIUM DECREASED 1235 0.0655
211 LIPASE INCREASED 501 0.0653
212 HYPOPHOSPHATAEMIA 483 0.0653
213 PERIORBITAL OEDEMA 338 0.0650
214 THERAPY CHANGE 637 0.0647
215 BLOOD MAGNESIUM DECREASED 559 0.0647
216 ORGANISING PNEUMONIA 321 0.0647
217 FATIGUE 50171 0.0644
218 PRODUCT DOSE OMISSION IN ERROR 1819 0.0642
219 GLOSSITIS 227 0.0639
220 GINGIVAL PAIN 508 0.0638
221 SUSPECTED OFF LABEL USE 287 0.0635
222 SKIN MASS 423 0.0633
223 BRAIN NEOPLASM 581 0.0632
224 ENTEROCOLITIS 362 0.0626
225 GENERALISED OEDEMA 776 0.0626
226 TRANSFUSION 655 0.0625
227 EATING DISORDER 1326 0.0622
228 KIDNEY TRANSPLANT REJECTION 298 0.0620
229 HEPATIC ENZYME ABNORMAL 309 0.0619
230 BLOOD CREATININE INCREASED 4039 0.0618
231 TONGUE DISCOMFORT 262 0.0617
232 LUNG INFILTRATION 544 0.0615
233 NASAL DRYNESS 385 0.0614
234 CYSTITIS HAEMORRHAGIC 247 0.0612
235 CARDIAC TAMPONADE 288 0.0605
236 PROSTATOMEGALY 238 0.0605
237 ALOPECIA 11893 0.0605
238 MOUTH HAEMORRHAGE 444 0.0605
239 DEHYDRATION 8073 0.0605
240 SKIN ATROPHY 347 0.0602
241 HEPATIC FAILURE 1817 0.0602
242 PHOTOSENSITIVITY REACTION 992 0.0600
243 LEUKOPENIA 2993 0.0598
244 DIFFUSE LARGE B-CELL LYMPHOMA 461 0.0598
245 ECCHYMOSIS 410 0.0597
246 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 448 0.0596
247 ORAL DISORDER 432 0.0589
248 LEUKAEMIA 556 0.0589
249 SKIN LESION 1609 0.0586
250 GINGIVAL BLEEDING 799 0.0585
251 BASAL CELL CARCINOMA 906 0.0580
252 BLOOD CALCIUM DECREASED 650 0.0577
253 TRANSAMINASES INCREASED 1281 0.0576
254 LIVER FUNCTION TEST INCREASED 1235 0.0575
255 SKIN CANCER 1237 0.0574
256 HYPERBILIRUBINAEMIA 595 0.0574
257 BLOOD CREATINE INCREASED 254 0.0573
258 PERFORMANCE STATUS DECREASED 267 0.0572
259 NIGHT SWEATS 1838 0.0570
260 FLUID INTAKE REDUCED 284 0.0567
261 CHEILITIS 307 0.0567
262 IMMUNE SYSTEM DISORDER 746 0.0565
263 PROTEIN URINE PRESENT 281 0.0563
264 IMMUNODEFICIENCY 836 0.0560
265 SKIN DISORDER 1866 0.0559
266 HEPATOMEGALY 548 0.0557
267 RENAL IMPAIRMENT 4674 0.0556
268 FAECES SOFT 404 0.0555
269 HAIR COLOUR CHANGES 691 0.0555
270 HAEMOPTYSIS 1544 0.0553
271 DYSLIPIDAEMIA 280 0.0551
272 PNEUMONIA BACTERIAL 504 0.0549
273 PIGMENTATION DISORDER 339 0.0548
274 IMMUNE THROMBOCYTOPENIA 251 0.0548
275 CHOLECYSTITIS 651 0.0546
276 MUSCULOSKELETAL CHEST PAIN 845 0.0545
277 OSTEONECROSIS OF JAW 1348 0.0544
278 LYMPHOCYTE COUNT DECREASED 960 0.0543
279 CARDIOTOXICITY 484 0.0542
280 ASPARTATE AMINOTRANSFERASE INCREASED 2882 0.0542
281 PULMONARY OEDEMA 2424 0.0541
282 SKIN ULCER 1397 0.0540
283 ACUTE MYELOID LEUKAEMIA 842 0.0540
284 HYPERTENSION 11443 0.0540
285 ODYNOPHAGIA 319 0.0534
286 LIVER DISORDER 2340 0.0527
287 BLOOD THYROID STIMULATING HORMONE INCREASED 485 0.0527
288 PANCYTOPENIA 2935 0.0525
289 FEBRILE NEUTROPENIA 3483 0.0525
290 HYPERCALCAEMIA 648 0.0524
291 ASTHENIA 19725 0.0524
292 IMMUNOSUPPRESSION 460 0.0521
293 HAEMORRHAGIC STROKE 407 0.0521
294 INTESTINAL PERFORATION 584 0.0520
295 LUNG DISORDER 2546 0.0519
296 PATHOLOGICAL FRACTURE 261 0.0514
297 EYE OPERATION 237 0.0514
298 BLOOD POTASSIUM INCREASED 835 0.0514
299 COVID-19 PNEUMONIA 606 0.0513
300 CONSTIPATION 11155 0.0511
301 CHAPPED LIPS 222 0.0511
302 ENTEROCOCCAL INFECTION 247 0.0511
303 HYPERCHOLESTEROLAEMIA 493 0.0510
304 ESCHERICHIA URINARY TRACT INFECTION 217 0.0510
305 BLOOD POTASSIUM DECREASED 1535 0.0510
306 HYPOPHAGIA 1305 0.0510
307 ELECTROLYTE IMBALANCE 592 0.0509
308 GOUT 911 0.0507
309 PULMONARY THROMBOSIS 553 0.0507
310 NEPHROPATHY TOXIC 569 0.0506
311 GLOMERULAR FILTRATION RATE DECREASED 622 0.0506
312 NEUROPATHY PERIPHERAL 4805 0.0505
313 PULMONARY HAEMORRHAGE 394 0.0503
314 LUNG NEOPLASM 215 0.0503
315 LYMPHOPENIA 711 0.0502
316 EJECTION FRACTION DECREASED 779 0.0501
317 BRAIN OEDEMA 632 0.0500
318 ENERGY INCREASED 295 0.0499
319 ATRIAL FLUTTER 396 0.0496
320 YELLOW SKIN 232 0.0495
321 ONYCHOMYCOSIS 217 0.0494
322 PSEUDOMONAS INFECTION 424 0.0494
323 BLISTER 2774 0.0493
324 OESOPHAGITIS 539 0.0493
325 AGEUSIA 1230 0.0493
326 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1092 0.0492
327 BLOOD ALKALINE PHOSPHATASE INCREASED 1223 0.0492
328 IRON DEFICIENCY 221 0.0491
329 ALANINE AMINOTRANSFERASE INCREASED 3013 0.0490
330 PRODUCT DISTRIBUTION ISSUE 453 0.0488
331 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1383 0.0488
332 APHONIA 679 0.0486
333 GASTROINTESTINAL MOTILITY DISORDER 258 0.0482
334 PERIPHERAL SWELLING 7423 0.0481
335 GLOSSODYNIA 1075 0.0480
336 LACRIMATION INCREASED 1444 0.0477
337 BLOOD PRESSURE ABNORMAL 950 0.0477
338 SKIN INFECTION 536 0.0477
339 HYPERLIPIDAEMIA 570 0.0477
340 HERPES SIMPLEX 309 0.0475
341 LEUKOCYTOSIS 860 0.0475
342 COLITIS 1799 0.0474
343 DISEASE COMPLICATION 217 0.0474
344 HAIR GROWTH ABNORMAL 326 0.0471
345 HYDRONEPHROSIS 352 0.0470
346 CHOLECYSTITIS ACUTE 266 0.0469
347 ESCHERICHIA INFECTION 386 0.0469
348 CEREBRAL DISORDER 345 0.0466
349 BLOOD CALCIUM INCREASED 408 0.0465
350 HEPATIC CYTOLYSIS 593 0.0465
351 KLEBSIELLA INFECTION 235 0.0464
352 OEDEMA 2518 0.0464
353 ERYSIPELAS 231 0.0459
354 ENCEPHALITIS 317 0.0458
355 LARGE INTESTINE PERFORATION 318 0.0457
356 BLOOD URINE PRESENT 868 0.0457
357 INCORRECT DOSAGE ADMINISTERED 223 0.0456
358 OFF LABEL USE 39850 0.0455
359 IMPAIRED HEALING 1488 0.0453
360 SKIN FISSURES 884 0.0452
361 RENAL CYST 359 0.0452
362 RENAL DISORDER 2106 0.0452
363 HAIR TEXTURE ABNORMAL 602 0.0450
364 BLOOD PRESSURE INCREASED 6871 0.0449
365 ATELECTASIS 433 0.0448
366 WEIGHT DECREASED 12485 0.0447
367 ERYTHEMA MULTIFORME 417 0.0447
368 FAILURE TO THRIVE 232 0.0446
369 HAEMATEMESIS 1129 0.0445
370 EMBOLISM 368 0.0443
371 MALNUTRITION 493 0.0440
372 PNEUMONIA 14143 0.0436
373 INTERNAL HAEMORRHAGE 498 0.0435
374 PULMONARY ALVEOLAR HAEMORRHAGE 244 0.0435
375 HAEMATURIA 1487 0.0434
376 LEFT VENTRICULAR DYSFUNCTION 290 0.0433
377 NEOPLASM MALIGNANT 2885 0.0432
378 CEREBRAL HAEMORRHAGE 1544 0.0431
379 BLOOD UREA INCREASED 722 0.0431
380 PLEURISY 255 0.0429
381 HEPATITIS 1095 0.0428
382 GINGIVITIS 230 0.0426
383 DYSPNOEA EXERTIONAL 1600 0.0424
384 CANDIDA INFECTION 717 0.0424
385 DYSPHAGIA 4027 0.0424
386 HAEMATOMA 1098 0.0423
387 HAEMORRHAGE 4429 0.0423
388 HYPOACUSIS 1822 0.0423
389 SEPSIS 4718 0.0423
390 ARTHROPOD BITE 313 0.0422
391 MALIGNANT MELANOMA 563 0.0420
392 SKIN LACERATION 456 0.0419
393 MYOCARDITIS 480 0.0418
394 PYREXIA 14476 0.0418
395 DRY SKIN 5576 0.0417
396 CARDIAC FAILURE ACUTE 278 0.0417
397 OEDEMA PERIPHERAL 5068 0.0415
398 THROMBOSIS 3331 0.0414
399 PURPURA 366 0.0413
400 SPINAL PAIN 484 0.0413
401 RETINAL DETACHMENT 378 0.0411
402 CARDIAC FAILURE 3296 0.0410
403 THYROID DISORDER 626 0.0406
404 SUBDURAL HAEMATOMA 581 0.0405
405 HYPOCALCAEMIA 768 0.0405
406 RASH 17676 0.0405
407 ACUTE RESPIRATORY FAILURE 780 0.0405
408 CARDIOMYOPATHY 599 0.0405
409 SEPTIC SHOCK 1763 0.0405
410 HYPERGLYCAEMIA 1472 0.0404
411 BACTERAEMIA 479 0.0403
412 SKIN DISCOLOURATION 1852 0.0403
413 ORAL DISCOMFORT 560 0.0403
414 LUNG INFECTION 625 0.0402
415 INFECTION 5814 0.0401
416 GENERAL PHYSICAL HEALTH DETERIORATION 4646 0.0401
417 NECROSIS 223 0.0400
418 ILLNESS 4126 0.0400
419 FLATULENCE 2270 0.0400
420 NAUSEA 31657 0.0400
421 UROSEPSIS 368 0.0398
422 POST PROCEDURAL HAEMORRHAGE 464 0.0398
423 BACTERIAL INFECTION 743 0.0398
424 GENERAL PHYSICAL CONDITION ABNORMAL 268 0.0395
425 URINARY TRACT INFECTION 6731 0.0394
426 LUNG NEOPLASM MALIGNANT 1620 0.0394
427 BLOOD TRIGLYCERIDES INCREASED 696 0.0394
428 DRY MOUTH 3196 0.0394
429 HOT FLUSH 2964 0.0393
430 BOWEL MOVEMENT IRREGULARITY 300 0.0391
431 RESPIRATORY FAILURE 2854 0.0391
432 TONGUE DISORDER 283 0.0391
433 TERMINAL STATE 261 0.0390
434 RASH PUSTULAR 284 0.0390
435 HYPERSOMNIA 1117 0.0389
436 DRUG INTOLERANCE 3758 0.0389
437 JAUNDICE 1039 0.0386
438 ENTERITIS 247 0.0386
439 CATARACT 2298 0.0385
440 ULCER 613 0.0385
441 SENSITIVE SKIN 284 0.0385
442 HIP FRACTURE 1235 0.0384
443 SKIN HAEMORRHAGE 569 0.0384
444 HERPES VIRUS INFECTION 220 0.0382
445 LYMPHOMA 590 0.0381
446 CEREBRAL INFARCTION 931 0.0381
447 HYPERAESTHESIA 312 0.0379
448 EYE HAEMORRHAGE 506 0.0379
449 CELLULITIS 1910 0.0379
450 HEPATIC ENZYME INCREASED 2579 0.0378
451 COVID-19 6626 0.0377
452 LOCALISED INFECTION 909 0.0375
453 SUDDEN DEATH 397 0.0375
454 PULMONARY EMBOLISM 3565 0.0375
455 SCAB 427 0.0374
456 C-REACTIVE PROTEIN INCREASED 1356 0.0372
457 GAIT INABILITY 1245 0.0372
458 HYPERTHYROIDISM 539 0.0372
459 RASH MACULO-PAPULAR 824 0.0370
460 VOMITING 17378 0.0369
461 BLOOD PRESSURE SYSTOLIC INCREASED 720 0.0369
462 COUGH 10343 0.0368
463 PHOTOPSIA 233 0.0368
464 NODULE 481 0.0368
465 MUSCLE STRAIN 317 0.0366
466 CYSTITIS 1164 0.0365
467 HYPOKALAEMIA 1684 0.0364
468 CONCOMITANT DISEASE AGGRAVATED 225 0.0364
469 DUODENAL ULCER 257 0.0364
470 HAEMOLYTIC ANAEMIA 326 0.0364
471 RASH MACULAR 1272 0.0363
472 VITAMIN D DECREASED 311 0.0363
473 PRODUCT DOSE OMISSION 2374 0.0363
474 HEPATITIS B 219 0.0363
475 ACUTE CORONARY SYNDROME 300 0.0362
476 CLOSTRIDIUM DIFFICILE COLITIS 384 0.0362
477 DIZZINESS POSTURAL 351 0.0362
478 BREAST PAIN 385 0.0361
479 FLUID RETENTION 1833 0.0360
480 DYSGEUSIA 2675 0.0360
481 MEMORY IMPAIRMENT 4945 0.0360
482 MENINGITIS 240 0.0359
483 ILEUS 445 0.0358
484 INCREASED APPETITE 684 0.0358
485 HERNIA 692 0.0358
486 HEPATOCELLULAR INJURY 507 0.0357
487 TOOTH EXTRACTION 445 0.0357
488 HYPOXIA 1258 0.0357
489 HERPES ZOSTER 2052 0.0357
490 ELECTROCARDIOGRAM QT PROLONGED 1277 0.0355
491 FLANK PAIN 330 0.0352
492 LIVER FUNCTION TEST ABNORMAL 1022 0.0351
493 PYELONEPHRITIS 302 0.0348
494 BREAST MASS 234 0.0348
495 SURGERY 2041 0.0348
496 ORAL HERPES 679 0.0347
497 TOOTHACHE 629 0.0347
498 GASTROENTERITIS 507 0.0347
499 CLOSTRIDIUM DIFFICILE INFECTION 758 0.0347
500 HEAD DISCOMFORT 614 0.0346
501 MYELODYSPLASTIC SYNDROME 501 0.0346
502 HAEMORRHOIDS 675 0.0346
503 BLOOD CHOLESTEROL INCREASED 1613 0.0346
504 MYOSITIS 310 0.0345
505 GASTRITIS 909 0.0345
506 FACE OEDEMA 582 0.0345
507 FEELING COLD 958 0.0344
508 DRUG-INDUCED LIVER INJURY 1077 0.0343
509 PAROSMIA 259 0.0343
510 DYSPEPSIA 3375 0.0343
511 RETINAL HAEMORRHAGE 244 0.0342
512 TOOTH DISORDER 761 0.0342
513 ABDOMINAL DISCOMFORT 5734 0.0341
514 NEUTROPHIL COUNT INCREASED 350 0.0341
515 FAECES DISCOLOURED 741 0.0341
516 GASTRIC HAEMORRHAGE 393 0.0341
517 FACIAL PARALYSIS 291 0.0341
518 POOR QUALITY SLEEP 733 0.0340
519 SPINAL COMPRESSION FRACTURE 280 0.0338
520 THERAPY CESSATION 1738 0.0338
521 OCULAR DISCOMFORT 378 0.0336
522 ABDOMINAL DISTENSION 3504 0.0335
523 FURUNCLE 266 0.0335
524 ABDOMINAL PAIN 7787 0.0334
525 RESPIRATORY SYNCYTIAL VIRUS INFECTION 291 0.0334
526 DRY THROAT 337 0.0331
527 BLOOD CREATINE PHOSPHOKINASE INCREASED 953 0.0331
528 GASTRIC ULCER 629 0.0331
529 ABDOMINAL PAIN UPPER 6804 0.0330
530 HAEMOLYSIS 255 0.0330
531 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 272 0.0329
532 MYALGIA 5607 0.0329
533 GASTROENTERITIS VIRAL 595 0.0329
534 ABNORMAL FAECES 270 0.0329
535 URINE OUTPUT DECREASED 288 0.0329
536 SEASONAL ALLERGY 466 0.0329
537 MUSCLE SPASMS 6040 0.0329
538 POLYNEUROPATHY 394 0.0329
539 CENTRAL NERVOUS SYSTEM LESION 452 0.0329
540 DISSEMINATED INTRAVASCULAR COAGULATION 462 0.0328
541 VIRAL INFECTION 1087 0.0326
542 CORONAVIRUS INFECTION 215 0.0325
543 ANAL INCONTINENCE 292 0.0324
544 IRON DEFICIENCY ANAEMIA 299 0.0324
545 DEMENTIA 900 0.0322
546 RASH PRURITIC 1741 0.0321
547 HYPONATRAEMIA 1805 0.0320
548 PRODUCTIVE COUGH 1529 0.0320
549 HAEMORRHAGE INTRACRANIAL 477 0.0319
550 SMALL INTESTINAL OBSTRUCTION 392 0.0318
551 RIB FRACTURE 655 0.0318
552 SKIN REACTION 448 0.0318
553 SCIATICA 505 0.0316
554 LIMB INJURY 860 0.0316
555 TOOTH INFECTION 416 0.0315
556 HICCUPS 259 0.0315
557 CYTOKINE RELEASE SYNDROME 628 0.0313
558 RENAL TUBULAR NECROSIS 307 0.0313
559 DRUG ERUPTION 554 0.0312
560 DECUBITUS ULCER 254 0.0311
561 ORAL CANDIDIASIS 410 0.0311
562 ARTHRALGIA 12923 0.0310
563 APHASIA 938 0.0310
564 ACUTE RESPIRATORY DISTRESS SYNDROME 549 0.0310
565 OROPHARYNGEAL PAIN 2870 0.0310
566 BACK PAIN 7195 0.0309
567 MALAISE 13575 0.0309
568 LIP DRY 281 0.0309
569 DIVERTICULITIS 856 0.0309
570 SINUS DISORDER 611 0.0308
571 BONE DISORDER 562 0.0308
572 PRODUCT DOSE OMISSION ISSUE 9067 0.0308
573 DYSURIA 1132 0.0307
574 DEAFNESS 804 0.0307
575 HYPERTENSIVE CRISIS 342 0.0307
576 LIVER INJURY 753 0.0306
577 PULMONARY FIBROSIS 587 0.0306
578 ACUTE KIDNEY INJURY 4681 0.0306
579 PAIN IN EXTREMITY 9004 0.0305
580 TENDERNESS 318 0.0305
581 TOOTH FRACTURE 336 0.0304
582 BODY TEMPERATURE DECREASED 299 0.0303
583 LOW DENSITY LIPOPROTEIN INCREASED 235 0.0303
584 KIDNEY INFECTION 594 0.0302
585 CHOLESTASIS 578 0.0301
586 SUPRAVENTRICULAR TACHYCARDIA 288 0.0301
587 DEVICE RELATED INFECTION 463 0.0300
588 PELVIC FRACTURE 234 0.0300
589 HYPOMAGNESAEMIA 418 0.0300
590 ENCEPHALOPATHY 737 0.0300
591 SPINAL FRACTURE 600 0.0299
592 SKIN EXFOLIATION 2519 0.0298
593 GASTROINTESTINAL DISORDER 2665 0.0297
594 MUSCULOSKELETAL DISCOMFORT 512 0.0297
595 RENAL PAIN 315 0.0297
596 LIMB DISCOMFORT 918 0.0296
597 COGNITIVE DISORDER 1385 0.0296
598 HEPATIC CIRRHOSIS 557 0.0296
599 DIARRHOEA HAEMORRHAGIC 277 0.0296
600 NEPHROLITHIASIS 1359 0.0296
601 RENAL FAILURE 3934 0.0296
602 DRUG LEVEL DECREASED 301 0.0295
603 ALTERED STATE OF CONSCIOUSNESS 637 0.0294
604 BODY HEIGHT DECREASED 314 0.0293
605 DYSPNOEA 16580 0.0293
606 WOUND 816 0.0292
607 DRY EYE 1454 0.0291
608 FRUSTRATION TOLERANCE DECREASED 235 0.0291
609 NERVE COMPRESSION 268 0.0290
610 GASTROINTESTINAL INFECTION 260 0.0290
611 BLOOD PRESSURE FLUCTUATION 693 0.0288
612 SUBARACHNOID HAEMORRHAGE 294 0.0288
613 MELAENA 635 0.0288
614 RESPIRATORY TRACT INFECTION 749 0.0287
615 CHILLS 3353 0.0286
616 SPINAL OPERATION 352 0.0285
617 BACK DISORDER 463 0.0284
618 RASH GENERALISED 737 0.0284
619 HOSPITALISATION 4360 0.0283
620 TOXIC SKIN ERUPTION 285 0.0283
621 CARDIAC DISORDER 2646 0.0283
622 DERMATITIS 592 0.0282
623 MACULAR DEGENERATION 336 0.0281
624 LIGAMENT SPRAIN 278 0.0281
625 PERIPHERAL COLDNESS 386 0.0281
626 APPENDICITIS 262 0.0280
627 WEIGHT FLUCTUATION 292 0.0279
628 FUNGAL INFECTION 926 0.0278
629 POLLAKIURIA 1156 0.0277
630 INTESTINAL OBSTRUCTION 1040 0.0276
631 GASTROINTESTINAL PAIN 303 0.0275
632 FALL 9166 0.0275
633 INCONTINENCE 291 0.0275
634 TEMPERATURE INTOLERANCE 284 0.0275
635 PRODUCT USE IN UNAPPROVED INDICATION 6818 0.0275
636 PRODUCT USE COMPLAINT 433 0.0275
637 GROIN PAIN 241 0.0274
638 NOCTURIA 333 0.0274
639 EYE INFECTION 309 0.0273
640 MYOPATHY 236 0.0273
641 UPPER-AIRWAY COUGH SYNDROME 225 0.0273
642 DEPRESSED MOOD 1443 0.0273
643 PULMONARY CONGESTION 359 0.0272
644 NEURALGIA 662 0.0272
645 STAPHYLOCOCCAL INFECTION 898 0.0272
646 DRUG LEVEL INCREASED 450 0.0272
647 THYROID CANCER 327 0.0271
648 SWELLING FACE 1769 0.0271
649 RETCHING 579 0.0271
650 CARDIOMEGALY 334 0.0271
651 WOUND INFECTION 297 0.0271
652 RHINORRHOEA 1747 0.0270
653 HAEMATOCHEZIA 1490 0.0270
654 MUSCULOSKELETAL PAIN 1405 0.0268
655 OROPHARYNGEAL DISCOMFORT 241 0.0267
656 UPPER GASTROINTESTINAL HAEMORRHAGE 448 0.0266
657 DEEP VEIN THROMBOSIS 1730 0.0266
658 SCRATCH 280 0.0265
659 UPPER RESPIRATORY TRACT INFECTION 1226 0.0265
660 HEAD INJURY 836 0.0264
661 PANCREATITIS ACUTE 593 0.0264
662 NASOPHARYNGITIS 4848 0.0263
663 UVEITIS 356 0.0262
664 ACNE 1990 0.0262
665 SARS-COV-2 TEST POSITIVE 346 0.0262
666 CHOLELITHIASIS 857 0.0261
667 DRUG INTERACTION 4143 0.0261
668 ISCHAEMIC STROKE 465 0.0260
669 VITREOUS FLOATERS 255 0.0259
670 GASTROOESOPHAGEAL REFLUX DISEASE 2088 0.0259
671 INFLUENZA 2892 0.0259
672 GASTROINTESTINAL HAEMORRHAGE 2167 0.0259
673 MENTAL STATUS CHANGES 719 0.0259
674 RESPIRATORY DISORDER 774 0.0258
675 CONFUSIONAL STATE 4173 0.0258
676 PANCREATITIS 1364 0.0258
677 PRODUCT USE ISSUE 4842 0.0257
678 TRANSIENT ISCHAEMIC ATTACK 869 0.0257
679 DIPLOPIA 667 0.0257
680 DIZZINESS 12778 0.0256
681 EAR PAIN 498 0.0256
682 PAIN OF SKIN 687 0.0255
683 PULMONARY HYPERTENSION 531 0.0255
684 PRODUCT PRESCRIBING ISSUE 555 0.0255
685 PERICARDITIS 428 0.0254
686 ACUTE MYOCARDIAL INFARCTION 751 0.0254
687 INFLAMMATION 1314 0.0254
688 PHOTOPHOBIA 478 0.0254
689 ARRHYTHMIA 1203 0.0254
690 WEIGHT INCREASED 5677 0.0253
691 SPEECH DISORDER 1328 0.0253
692 CYST 314 0.0253
693 DIABETES MELLITUS 1924 0.0252
694 GALLBLADDER DISORDER 450 0.0252
695 MUSCULAR WEAKNESS 2865 0.0252
696 SLUGGISHNESS 257 0.0252
697 THERAPY NON-RESPONDER 1129 0.0251
698 BLADDER DISORDER 249 0.0251
699 PNEUMONIA ASPIRATION 626 0.0250
700 HEPATIC STEATOSIS 466 0.0250
701 BALANCE DISORDER 2160 0.0250
702 HYPERKALAEMIA 876 0.0250
703 EAR DISCOMFORT 256 0.0249
704 MITRAL VALVE INCOMPETENCE 282 0.0249
705 EMOTIONAL DISORDER 767 0.0249
706 CHROMATURIA 560 0.0248
707 SPINAL DISORDER 234 0.0247
708 SWELLING 2312 0.0247
709 EYE DISORDER 812 0.0247
710 FRACTURE 467 0.0246
711 TOOTH ABSCESS 251 0.0246
712 GASTRIC DISORDER 841 0.0245
713 BODY TEMPERATURE INCREASED 499 0.0244
714 UPPER LIMB FRACTURE 485 0.0243
715 RASH PAPULAR 545 0.0243
716 INTENTIONAL DOSE OMISSION 692 0.0242
717 DENTAL CARIES 268 0.0242
718 FOLLICULITIS 254 0.0242
719 ERUCTATION 466 0.0241
720 DYSSTASIA 702 0.0240
721 PRURITUS 9219 0.0240
722 PRODUCT DISPENSING ERROR 522 0.0239
723 COAGULOPATHY 399 0.0239
724 BLINDNESS 975 0.0239
725 HEMIPARESIS 405 0.0239
726 SEIZURE 2752 0.0238
727 HEADACHE 14933 0.0238
728 SINUS CONGESTION 321 0.0237
729 ARTHRITIS 1864 0.0237
730 GAIT DISTURBANCE 4529 0.0236
731 HYPOAESTHESIA 3537 0.0236
732 MADAROSIS 273 0.0235
733 HEART RATE IRREGULAR 530 0.0234
734 KNEE OPERATION 230 0.0234
735 THERAPY INTERRUPTED 1662 0.0232
736 CARDIAC FAILURE CONGESTIVE 1865 0.0232
737 MYOCARDIAL ISCHAEMIA 264 0.0232
738 AMNESIA 1492 0.0229
739 PAIN 14082 0.0229
740 SECRETION DISCHARGE 287 0.0229
741 VISUAL IMPAIRMENT 2835 0.0229
742 EYE SWELLING 851 0.0229
743 OSTEOMYELITIS 414 0.0228
744 INSOMNIA 6073 0.0228
745 HEART RATE DECREASED 800 0.0228
746 NERVE INJURY 253 0.0227
747 LETHARGY 1307 0.0227
748 LOWER LIMB FRACTURE 436 0.0227
749 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1085 0.0226
750 THERAPEUTIC RESPONSE UNEXPECTED 1013 0.0226
751 NECK PAIN 1261 0.0225
752 ADVERSE DRUG REACTION 2026 0.0225
753 EAR INFECTION 600 0.0225
754 HIP ARTHROPLASTY 344 0.0224
755 PRODUCT PRESCRIBING ERROR 535 0.0224
756 RASH ERYTHEMATOUS 1065 0.0223
757 URINARY RETENTION 742 0.0222
758 RESPIRATORY DISTRESS 612 0.0222
759 CHEST PAIN 4100 0.0221
760 JOINT INJURY 471 0.0220
761 CEREBROVASCULAR ACCIDENT 3732 0.0220
762 WRIST FRACTURE 264 0.0220
763 AGRANULOCYTOSIS 409 0.0220
764 ILL-DEFINED DISORDER 1333 0.0219
765 HUNGER 304 0.0218
766 BRONCHITIS 1614 0.0218
767 NERVOUS SYSTEM DISORDER 674 0.0216
768 SYNCOPE 2159 0.0216
769 CONJUNCTIVITIS 400 0.0215
770 MUSCLE ATROPHY 273 0.0215
771 THIRST 385 0.0215
772 MUSCULOSKELETAL DISORDER 410 0.0215
773 FREQUENT BOWEL MOVEMENTS 580 0.0214
774 GLAUCOMA 413 0.0214
775 JOINT SWELLING 2586 0.0214
776 HEPATIC CANCER 514 0.0214
777 MICTURITION URGENCY 243 0.0213
778 EYELID OEDEMA 247 0.0212
779 PHARYNGITIS 263 0.0212
780 FEELING ABNORMAL 5072 0.0211
781 HIATUS HERNIA 274 0.0211
782 SLEEP DISORDER 1493 0.0211
783 HYPOTENSION 4238 0.0211
784 CHOLECYSTECTOMY 240 0.0210
785 ASPIRATION 230 0.0210
786 TINNITUS 964 0.0210
787 RECTAL HAEMORRHAGE 900 0.0209
788 INTENTIONAL PRODUCT USE ISSUE 1835 0.0209
789 BLOOD PRESSURE DECREASED 1391 0.0209
790 SINUSITIS 2128 0.0207
791 FISTULA 233 0.0207
792 VENTRICULAR FIBRILLATION 230 0.0207
793 DISORIENTATION 818 0.0206
794 JOINT STIFFNESS 539 0.0205
795 PAIN IN JAW 581 0.0205
796 BACK INJURY 223 0.0205
797 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1124 0.0205
798 PARALYSIS 293 0.0204
799 CHOKING 399 0.0204
800 VERTIGO 1245 0.0204
801 ACUTE HEPATIC FAILURE 279 0.0204
802 ANOREXIA 262 0.0203
803 HEART RATE INCREASED 2001 0.0202
804 SOMNOLENCE 4061 0.0201
805 EPILEPSY 616 0.0201
806 VASCULITIS 234 0.0201
807 ANGINA PECTORIS 573 0.0200
808 BURNING SENSATION 1401 0.0200
809 PRESYNCOPE 485 0.0199
810 ACCIDENT 236 0.0197
811 BLOOD GLUCOSE ABNORMAL 364 0.0197
812 NASAL CONGESTION 1153 0.0196
813 VISION BLURRED 2692 0.0196
814 SINUS TACHYCARDIA 277 0.0195
815 ABSCESS 310 0.0194
816 POST PROCEDURAL COMPLICATION 370 0.0192
817 OSTEOPENIA 292 0.0192
818 FEMUR FRACTURE 593 0.0191
819 PERITONITIS 396 0.0191
820 OXYGEN SATURATION DECREASED 1068 0.0190
821 HYPOAESTHESIA ORAL 286 0.0190
822 KNEE ARTHROPLASTY 398 0.0189
823 VENTRICULAR TACHYCARDIA 311 0.0188
824 NEUROTOXICITY 328 0.0187
825 ERYTHEMA 3842 0.0187
826 MULTI-ORGAN FAILURE 322 0.0186
827 URINARY INCONTINENCE 551 0.0186
828 BEDRIDDEN 244 0.0185
829 LOSS OF CONSCIOUSNESS 2357 0.0184
830 MOBILITY DECREASED 1320 0.0184
831 INCORRECT DOSE ADMINISTERED 4167 0.0182
832 PARAESTHESIA 2851 0.0181
833 RESPIRATORY TRACT CONGESTION 287 0.0180
834 BREAST CANCER 1677 0.0180
835 QUALITY OF LIFE DECREASED 241 0.0179
836 DERMATITIS ALLERGIC 225 0.0179
837 STEVENS-JOHNSON SYNDROME 397 0.0178
838 DISEASE RECURRENCE 847 0.0178
839 COLON CANCER 265 0.0178
840 MENTAL IMPAIRMENT 431 0.0178
841 SNEEZING 395 0.0176
842 THINKING ABNORMAL 326 0.0175
843 CARPAL TUNNEL SYNDROME 245 0.0175
844 SWOLLEN TONGUE 545 0.0174
845 MOVEMENT DISORDER 560 0.0174
846 ANKLE FRACTURE 269 0.0174
847 PALLOR 471 0.0173
848 FOOT FRACTURE 327 0.0172
849 NERVOUSNESS 893 0.0171
850 CARDIO-RESPIRATORY ARREST 711 0.0170
851 COMA 806 0.0169
852 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 876 0.0168
853 TACHYCARDIA 1483 0.0167
854 RHABDOMYOLYSIS 696 0.0167
855 MYOCARDIAL INFARCTION 2908 0.0167
856 BLINDNESS UNILATERAL 234 0.0166
857 DELIRIUM 575 0.0166
858 EXTRA DOSE ADMINISTERED 671 0.0165
859 TUBULOINTERSTITIAL NEPHRITIS 310 0.0165
860 TREATMENT FAILURE 1370 0.0165
861 CHEST DISCOMFORT 1691 0.0165
862 ARTHROPATHY 913 0.0164
863 DISCOMFORT 999 0.0164
864 LIP SWELLING 533 0.0160
865 DYSARTHRIA 600 0.0159
866 THROAT IRRITATION 714 0.0159
867 MOOD ALTERED 434 0.0159
868 PALPITATIONS 1861 0.0159
869 UNEVALUABLE EVENT 1201 0.0159
870 OSTEOPOROSIS 652 0.0158
871 BLOOD GLUCOSE DECREASED 761 0.0158
872 CARDIAC ARREST 1307 0.0158
873 CORONARY ARTERY OCCLUSION 217 0.0158
874 HYPOGLYCAEMIA 763 0.0157
875 LOWER RESPIRATORY TRACT INFECTION 699 0.0154
876 TOXICITY TO VARIOUS AGENTS 2591 0.0153
877 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2766 0.0153
878 ORTHOSTATIC HYPOTENSION 267 0.0153
879 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 445 0.0152
880 DRUG DOSE OMISSION 2500 0.0151
881 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 389 0.0151
882 FEELING HOT 923 0.0150
883 PRODUCT PHYSICAL ISSUE 303 0.0150
884 HYPOKINESIA 218 0.0150
885 MENTAL DISORDER 651 0.0149
886 RENAL CANCER 711 0.0149
887 HALLUCINATION 1117 0.0148
888 PROCEDURAL PAIN 411 0.0148
889 DEPRESSION 3355 0.0147
890 INTERVERTEBRAL DISC PROTRUSION 322 0.0147
891 ADVERSE EVENT 1357 0.0147
892 MUSCLE TIGHTNESS 237 0.0146
893 SHOCK 336 0.0146
894 ABDOMINAL PAIN LOWER 369 0.0146
895 ABASIA 360 0.0146
896 CONDITION AGGRAVATED 4396 0.0144
897 CARDIOVASCULAR DISORDER 366 0.0144
898 OSTEONECROSIS 470 0.0143
899 RESTLESS LEGS SYNDROME 258 0.0142
900 LOCAL SWELLING 246 0.0141
901 BLOOD GLUCOSE INCREASED 2657 0.0141
902 CIRCULATORY COLLAPSE 239 0.0140
903 EOSINOPHILIA 245 0.0140
904 EYE PAIN 785 0.0139
905 OSTEOARTHRITIS 585 0.0138
906 ANXIETY 3892 0.0137
907 ROAD TRAFFIC ACCIDENT 571 0.0136
908 TREMOR 2250 0.0135
909 MUSCULOSKELETAL STIFFNESS 1186 0.0135
910 RENAL FAILURE ACUTE 568 0.0134
911 CORONARY ARTERY DISEASE 404 0.0133
912 ECZEMA 694 0.0132
913 DISTURBANCE IN ATTENTION 706 0.0131
914 HYPERSENSITIVITY 2423 0.0130
915 COLD SWEAT 230 0.0130
916 CHRONIC KIDNEY DISEASE 990 0.0130
917 HYPERHIDROSIS 1667 0.0129
918 PRURITUS GENERALISED 279 0.0129
919 INTERNATIONAL NORMALISED RATIO INCREASED 361 0.0126
920 METABOLIC ACIDOSIS 398 0.0124
921 GLYCOSYLATED HAEMOGLOBIN INCREASED 313 0.0124
922 PELVIC PAIN 223 0.0123
923 TOOTH LOSS 252 0.0121
924 MIGRAINE 1139 0.0119
925 OCULAR HYPERAEMIA 564 0.0119
926 SLEEP APNOEA SYNDROME 226 0.0118
927 EYE PRURITUS 396 0.0118
928 MIDDLE INSOMNIA 220 0.0118
929 BRADYCARDIA 624 0.0118
930 BREAST CANCER FEMALE 313 0.0117
931 URTICARIA 1963 0.0117
932 HALLUCINATION, VISUAL 244 0.0115
933 DEPRESSED LEVEL OF CONSCIOUSNESS 456 0.0115
934 TYPE 2 DIABETES MELLITUS 388 0.0115
935 INFLUENZA LIKE ILLNESS 944 0.0115
936 PRESCRIBED UNDERDOSE 226 0.0113
937 INTENTIONAL PRODUCT MISUSE 991 0.0113
938 ANGIOEDEMA 494 0.0112
939 IRRITABLE BOWEL SYNDROME 234 0.0109
940 CRYING 395 0.0109
941 DRUG INEFFECTIVE 14175 0.0107
942 TREATMENT NONCOMPLIANCE 582 0.0106
943 IRRITABILITY 636 0.0106
944 THERAPEUTIC RESPONSE DECREASED 632 0.0104
945 SKIN IRRITATION 475 0.0104
946 UNRESPONSIVE TO STIMULI 264 0.0102
947 RESTLESSNESS 373 0.0102
948 WHEEZING 595 0.0100
949 VISUAL ACUITY REDUCED 329 0.0099
950 DIABETIC KETOACIDOSIS 231 0.0096
951 RESPIRATORY ARREST 263 0.0095
952 MOOD SWINGS 300 0.0094
953 RENAL INJURY 264 0.0089
954 UNDERDOSE 646 0.0088
955 THERAPEUTIC PRODUCT EFFECT DECREASED 396 0.0088
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1790 0.0088
957 VAGINAL HAEMORRHAGE 382 0.0088
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 619 0.0087
959 ANGER 288 0.0085
960 FLUSHING 856 0.0084
961 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 597 0.0084
962 THROAT TIGHTNESS 220 0.0081
963 ABNORMAL BEHAVIOUR 320 0.0081
964 FEAR 217 0.0081
965 ANAPHYLACTIC REACTION 432 0.0078
966 AGITATION 574 0.0078
967 PSYCHOTIC DISORDER 224 0.0076
968 NO ADVERSE EVENT 1336 0.0074
969 INFUSION RELATED REACTION 473 0.0071
970 LACTIC ACIDOSIS 224 0.0069
971 ACCIDENTAL OVERDOSE 247 0.0067
972 PANIC ATTACK 238 0.0065
973 EYE IRRITATION 368 0.0064
974 PROSTATE CANCER 514 0.0064
975 SKIN BURNING SENSATION 456 0.0064
976 DYSKINESIA 250 0.0061
977 MEDICATION ERROR 334 0.0060
978 AGGRESSION 296 0.0059
979 ASTHMA 653 0.0058
980 CONVULSION 330 0.0058
981 INJURY 386 0.0055
982 COLITIS ULCERATIVE 238 0.0053
983 PRODUCT STORAGE ERROR 376 0.0043
984 BLADDER CANCER 226 0.0038
985 SUICIDAL IDEATION 292 0.0032
986 PSORIASIS 341 0.0026
987 OVERDOSE 553 0.0026
988 RHEUMATOID ARTHRITIS 283 0.0025
989 MATERNAL EXPOSURE DURING PREGNANCY 220 0.0025
990 EMOTIONAL DISTRESS 275 0.0023
991 INJECTION SITE PAIN 514 0.0017